{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:29:49Z","timestamp":1780514989586,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,13]]},"DOI":"10.7759\/cureus.106985","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:22:52Z","timestamp":1776111772000},"source":"Crossref","is-referenced-by-count":1,"title":["Eosinophilic Granulomatosis With Polyangiitis (EGPA) Manifesting as Giant Cell Arteritis After Initiating Treatment With Dupilumab: An Unusual Clinical Presentation"],"prefix":"10.7759","author":[{"given":"Sameen","family":"Zafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopkiran","family":"Panesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya L","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi G","year":"2023","unstructured":"Emmi G, Bettiol A, Gelain E, et al.. Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat Rev Rheumatol. 2023, 19:378-93. 10.1038\/s41584-023-00958-w","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/art.41982","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"74","author":"Grayson PC","year":"2022","unstructured":"Grayson PC, Ponte C, Suppiah R, et al.. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis. Arthritis Rheumatol. 2022, 74:386-92. 10.1002\/art.41982","journal-title":"Arthritis Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2024.2304556","article-title":"Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence","volume":"24","author":"Caminati M","year":"2024","unstructured":"Caminati M, Micheletto C, Norelli F, et al.. Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence. Expert Opin Biol Ther. 2024, 24:15-23. 10.1080\/14712598.2024.2304556","journal-title":"Expert Opin Biol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin24.528","article-title":"Eosinophilic complications during dupilumab therapy for type 2 diseases: a systematic review","volume":"63","author":"Lazzeroni M","year":"2025","unstructured":"Lazzeroni M, Kemp P, Fokkens WJ, Reitsma S. Eosinophilic complications during dupilumab therapy for type 2 diseases: a systematic review. Rhinology. 2025, 63:386-96. 10.4193\/Rhin24.528","journal-title":"Rhinology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175721","article-title":"Changes in peripheral blood eosinophil counts and risk of eosinophilic granulomatosis with polyangiitis onset after initiation of dupilumab administration in adult patients with asthma","volume":"12","author":"Kushima Y","year":"2023","unstructured":"Kushima Y, Shimizu Y, Hoshi H, et al.. Changes in peripheral blood eosinophil counts and risk of eosinophilic granulomatosis with polyangiitis onset after initiation of dupilumab administration in adult patients with asthma. J Clin Med. 2023, 12:5721. 10.3390\/jcm12175721","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.20230727.eg","article-title":"Eosinophilic granulomatosis with polyangiitis presenting as vasculitis in the temporal artery","volume":"34","author":"Kintrilis N","year":"2023","unstructured":"Kintrilis N. Eosinophilic granulomatosis with polyangiitis presenting as vasculitis in the temporal artery. Mediterr J Rheumatol. 2023, 34:377-80. 10.31138\/mjr.20230727.eg","journal-title":"Mediterr J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/24725625.2021.1893944","article-title":"Temporal arteritis as an initial manifestation of eosinophilic granulomatosis with polyangiitis: a case report and a literature review","volume":"5","author":"Nishimura T","year":"2021","unstructured":"Nishimura T, Hosai M, Yamasaki R, Oiwa H. Temporal arteritis as an initial manifestation of eosinophilic granulomatosis with polyangiitis: a case report and a literature review. Mod Rheumatol Case Rep. 2021, 5:337-41. 10.1080\/24725625.2021.1893944","journal-title":"Mod Rheumatol Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2413449","article-title":"A Phase 3 trial of upadacitinib for giant-cell arteritis","volume":"392","author":"Blockmans D","year":"2025","unstructured":"Blockmans D, Penn SK, Setty AR, et al.. A Phase 3 trial of upadacitinib for giant-cell arteritis. N Engl J Med. 2025, 392:2013-24. 10.1056\/NEJMoa2413449","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung SA","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, et al.. 2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2021, 73:1366-83. 10.1002\/art.41773","journal-title":"Arthritis Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25218","article-title":"Exacerbation of eosinophilic granulomatosis with polyangiitis after administering dupilumab for severe asthma and eosinophilic rhinosinusitis with nasal polyposis","volume":"14","author":"Tanaka S","year":"2022","unstructured":"Tanaka S, Tsuji T, Shiotsu S, Yuba T, Hiraoka N. Exacerbation of eosinophilic granulomatosis with polyangiitis after administering dupilumab for severe asthma and eosinophilic rhinosinusitis with nasal polyposis. Cureus. 2022, 14:e25218. 10.7759\/cureus.25218","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27670","article-title":"Dupilumab-associated eosinophilic granulomatosis with polyangiitis","volume":"14","author":"Persaud P","year":"2022","unstructured":"Persaud P, Karmali R, Sankar P, Majid M. Dupilumab-associated eosinophilic granulomatosis with polyangiitis. Cureus. 2022, 14:e27670. 10.7759\/cureus.27670","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2022.03.006","article-title":"Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab","volume":"1","author":"Yamazaki K","year":"2022","unstructured":"Yamazaki K, Nomizo T, Hatanaka K, Hayama N, Oguma T, Asano K. Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab. J Allergy Clin Immunol Glob. 2022, 1:180-2. 10.1016\/j.jacig.2022.03.006","journal-title":"J Allergy Clin Immunol Glob"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02415-6","article-title":"Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report","volume":"23","author":"Suzaki I","year":"2023","unstructured":"Suzaki I, Tanaka A, Yanai R, Maruyama Y, Kamimura S, Hirano K, Kobayashi H. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report. BMC Pulm Med. 2023, 23:130. 10.1186\/s12890-023-02415-6","journal-title":"BMC Pulm Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.7990-21","article-title":"Severe asthma where eosinophilic granulomatosis with polyangiitis became apparent after the discontinuation of dupilumab","volume":"61","author":"Ikeda M","year":"2022","unstructured":"Ikeda M, Ohshima N, Kawashima M, Shiina M, Kitani M, Suzukawa M. Severe asthma where eosinophilic granulomatosis with polyangiitis became apparent after the discontinuation of dupilumab. Intern Med. 2022, 61:755-9. 10.2169\/internalmedicine.7990-21","journal-title":"Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/451424-eosinophilic-granulomatosis-with-polyangiitis-egpa-manifesting-as-giant-cell-arteritis-after-initiating-treatment-with-dupilumab-an-unusual-clinical-presentation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:22:53Z","timestamp":1776111773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/451424-eosinophilic-granulomatosis-with-polyangiitis-egpa-manifesting-as-giant-cell-arteritis-after-initiating-treatment-with-dupilumab-an-unusual-clinical-presentation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.106985","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,13]]}}}